Timing of inhibitor development in more than 1000 previously untreated patients with severe hemophilia A

Clinical trials and registries in haemophilia: Opponents or collaborators? Comparison of PUP data derived from different data sources

(2018) C. Keipert et al.   HAEMOPHILIA

Factor VIII products and inhibitor development in previously treated patients with severe or moderately severe hemophilia A: a systematic review

(2018) S. Hassan et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A

(2017) Thierry Calvez et al.   HAEMATOLOGICA

Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A

(2017) Thierry Calvez et al.   HAEMATOLOGICA

A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A

(2016) Flora Peyvandi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Inhibitor development in haemophilia according to concentrate

(2015) Riita Lassila et al.   THROMBOSIS AND HAEMOSTASIS

Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A

(2015) Maria Elisa Mancuso et al.   THROMBOSIS AND HAEMOSTASIS

Bleeding before prophylaxis in severe hemophilia: paradigm shift over two decades

(2014) A. Nijdam et al.   HAEMATOLOGICA

Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry

(2014) K. Fischer et al.   HAEMOPHILIA

Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study

(2013) S. C. Gouw et al.   BLOOD

Inhibitor development in previously treated hemophilia A patients: a systematic review, meta-analysis, and meta-regression

(2013) M. Xi et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review

(2010) A. IORIO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS